18F-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality
- PMID: 28336786
- DOI: 10.2967/jnumed.117.191981
18F-FDG PET/CT Optimizes Treatment in Staphylococcus Aureus Bacteremia and Is Associated with Reduced Mortality
Abstract
Metastatic infection is an important complication of Staphylococcus aureus bacteremia (SAB). Early diagnosis of metastatic infection is crucial, because specific treatment is required. However, metastatic infection can be asymptomatic and difficult to detect. In this study, we investigated the role of 18F-FDG PET/CT in patients with SAB for detection of metastatic infection and its consequences for treatment and outcome. Methods: All patients with SAB at Radboud University Medical Center were included between January 2013 and April 2016. Clinical data and results of 18F-FDG PET/CT and other imaging techniques, including echocardiography, were collected. Primary outcomes were newly diagnosed metastatic infection by 18F-FDG PET/CT, subsequent treatment modifications, and patient outcome. Results: A total of 184 patients were included, and 18F-FDG PET/CT was performed in 105 patients, of whom 99 had a high-risk bacteremia. 18F-FDG PET/CT detected metastatic infectious foci in 73.7% of these high-risk patients. In 71.2% of patients with metastatic infection, no signs and symptoms suggesting metastatic complications were present before 18F-FDG PET/CT was performed. 18F-FDG PET/CT led to a total of 104 treatment modifications in 74 patients. Three-month mortality was higher in high-risk bacteremia patients without 18F-FDG PET/CT performed than in those in whom 18F-FDG PET/CT was performed (32.7% vs. 12.4%, P = 0.003). In multivariate analysis, 18F-FDG PET/CT was the only factor independently associated with reduced mortality (P = 0.005; odds ratio, 0.204; 95% confidence interval, 0.066-0.624). A higher comorbidity score was independently associated with increased mortality (P = 0.003; odds ratio, 1.254; 95% confidence interval, 1.078-1.457). Conclusion:18F-FDG PET/CT is a valuable technique for early detection of metastatic infectious foci, often leading to treatment modification. Performing 18F-FDG PET/CT is associated with significantly reduced 3-mo mortality.
Keywords: 18F-FDG PET/CT; Staphylococcus aureus; metastatic infection.
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.
Similar articles
-
18F-FDG PET/CT-Guided Treatment Duration in Patients with High-Risk Staphylococcus Aureus Bacteremia: A Proof of Principle.J Nucl Med. 2019 Jul;60(7):998-1002. doi: 10.2967/jnumed.118.221929. Epub 2018 Dec 14. J Nucl Med. 2019. PMID: 30552202
-
18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia.J Nucl Med. 2010 Aug;51(8):1234-40. doi: 10.2967/jnumed.109.072371. Epub 2010 Jul 21. J Nucl Med. 2010. PMID: 20660384
-
Impact of [18F] FDG PET/CT on outcomes in patients with Staphylococcus aureus bacteremia: A retrospective single-center experience.Infect Dis Now. 2024 Oct;54(7):104977. doi: 10.1016/j.idnow.2024.104977. Epub 2024 Sep 12. Infect Dis Now. 2024. PMID: 39276874
-
[18F]FDG-PET/CT in Staphylococcus aureus bacteremia: a systematic review.BMC Infect Dis. 2022 Mar 24;22(1):282. doi: 10.1186/s12879-022-07273-x. BMC Infect Dis. 2022. PMID: 35331165 Free PMC article.
-
Evidence of Clinical Impact Supports a New Petition for Medicare Coverage of 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in the Evaluation of Staphylococcus aureus Bacteremia: A Focused Literature Review and Call to Action.Clin Infect Dis. 2022 Oct 12;75(8):1457-1461. doi: 10.1093/cid/ciac363. Clin Infect Dis. 2022. PMID: 35535794 Review.
Cited by
-
Real-world assessment of the clinical utility of whole body 18F-FDG PET/CT in the diagnosis of infection.PLoS One. 2022 Nov 14;17(11):e0277403. doi: 10.1371/journal.pone.0277403. eCollection 2022. PLoS One. 2022. PMID: 36374789 Free PMC article.
-
Development of quality indicators for the management of Staphylococcus aureus bacteraemia.J Antimicrob Chemother. 2019 Nov 1;74(11):3344-3351. doi: 10.1093/jac/dkz342. J Antimicrob Chemother. 2019. PMID: 31393551 Free PMC article.
-
Clinical revenues of selective use of [18F]-FDG-PET/CT scanning in the management of Staphylococcus aureus bacteremia.Eur J Clin Microbiol Infect Dis. 2025 Apr;44(4):895-904. doi: 10.1007/s10096-025-05052-5. Epub 2025 Feb 8. Eur J Clin Microbiol Infect Dis. 2025. PMID: 39921696 Free PMC article.
-
PET/CT Imaging for Personalized Management of Infectious Diseases.J Pers Med. 2021 Feb 16;11(2):133. doi: 10.3390/jpm11020133. J Pers Med. 2021. PMID: 33669375 Free PMC article. Review.
-
Septic Pulmonary Emboli Detected by 18F-FDG PET/CT in a Patient with Central Venous Catheter-Related Staphylococcus aureus Bacteremia.Diagnostics (Basel). 2022 Oct 13;12(10):2479. doi: 10.3390/diagnostics12102479. Diagnostics (Basel). 2022. PMID: 36292168 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous